Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure ; day:3 ; month:10 ; year:2023 ; pages:1-11
Biologia ; (3.10.2023), 1-11
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Pavelka, Antonín
Vacek, Lukáš
Norek, Adam
Kobzová, Šárka
Janda, Lubomír
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11756-023-01539-8
- URN
-
urn:nbn:de:101:1-2023122421040794270662
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pavelka, Antonín
- Vacek, Lukáš
- Norek, Adam
- Kobzová, Šárka
- Janda, Lubomír
- SpringerLink (Online service)
Other Objects (12)
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Expression of a novel NaD1 recombinant antimicrobial peptide enhances antifungal and insecticidal activities
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Utilization of a recombinant defensin from Maize (Zea mays L.) as a potential antimicrobial peptide
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Expression of a novel NaD1 recombinant antimicrobial peptide enhances antifungal and insecticidal activities
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Utilization of a recombinant defensin from Maize (Zea mays L.) as a potential antimicrobial peptide
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Expression of a novel NaD1 recombinant antimicrobial peptide enhances antifungal and insecticidal activities
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Utilization of a recombinant defensin from Maize (Zea mays L.) as a potential antimicrobial peptide
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides